Cisatracurium Besilate 10?mg / 5?mL Vial Wholesale price comparison

Cisatracurium Besilate 10?mg / 5?mL Vial Wholesale price comparison

$23.00

Cisatracurium besilate is an intermediate-acting, non-depolarizing neuromuscular blocking agent used in preclinical research for muscle relaxation, anesthesia modeling, and mechanical ventilation studies. It is one of the 10 stereoisomers of atracurium, offering greater potency and minimal histamine release. Each 5?mL vial contains 10?mg.
?? For laboratory research use only.?Please consult the staff for other purposes?

EMI starting from $0.00/month - View Plans
Compare

Description

Product Specifications

AttributeDetails
Product NameCisatracurium Besilate Injection
Generic NameCisatracurium Besilate (Nimbex®)
CAS Number96946?42?8
Molecular FormulaC??H??N?O??S? (besilate salt)
Molecular Weight~1243.5?g/mol en.wikipedia.org+4accessdata.fda.gov+4en.wikipedia.org+4pdr.net+2en.wikipedia.org+2pfizermedicalinformation.com+2
Dosage FormAqueous solution for IV injection
Strength10?mg per 5?mL vial (2?mg/mL)
Pack Size1 vial per box
Approval NumberH20183042 (China NMPA)
Product Code86901445002935
ManufacturerJiangsu Hengrui Pharmaceuticals Co., Ltd.
Barcode(Not specified)
StorageRefrigerate at 2–8?°C; protect from light
Intended UseLaboratory research only

Mechanism of Action

Cisatracurium competitively binds to nicotinic cholinergic receptors at the neuromuscular junction, preventing acetylcholine binding and blocking muscle contraction. It is metabolized via Hofmann elimination—organ-independent—making it suitable for varied preclinical models.


Research Applications & Pharmacology

  • Muscle relaxation models: Suitable for tracheal intubation, ventilation, and anesthesia simulation .

  • Pharmacokinetics: Onset ~2–4?min; effective duration ~55?min; half-life ~20–30?min; slower onset in geriatrics or renal impairment .

  • Comparative profile: Less histamine release and hemodynamic impact than atracurium, with faster recovery compared to vecuronium.


Safety Profile & Handling

  • Adverse events: Minimal histamine-mediated reactions (flushing, hypotension); rare bronchospasm .

  • Hypersensitivity: Anaphylaxis reported—emergency protocols required .

  • Lab use guidance: Administer IV with neuromuscular monitoring (e.g., train-of-four), maintain ventilatory support, have resuscitation and reversal agents available .


?? Research?Use Disclaimer

This product is intended exclusively for laboratory research. It is not approved for therapeutic, diagnostic, clinical, or veterinary use. Misuse may pose safety hazards and compromise study validity.

Additional information

Weight1.1 kg
Dimensions18 × 16 × 18 cm

Reviews

There are no reviews yet.

Be the first to review “Cisatracurium Besilate 10?mg / 5?mL Vial Wholesale price comparison”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare